Mesenchymal stem cell therapy and cognition in MS: Preliminary findings from a phase II clinical trial

Multiple Sclerosis and Related Disorders - Tập 61 - Trang 103779 - 2022
Jason A. Berard1,2, Mark S. Freedman1,2,3, Ruth Ann Marrie4, James J. Marriott4, Harold L. Atkins1,2,3, David Szwajcer4, David. W Courtman1,3, Simon Thebault1,3, Lisa A.S. Walker1,2,3,4,5
1The Ottawa Hospital Research Institute, Ottawa, Canada
2The University of Ottawa Brain and Mind Research Institute, Ottawa, Canada
3University of Ottawa, Department of Medicine, Ottawa, Canada
4Max Rady College of Medicine, Rady Faculty of Health Sciences, University of Manitoba, Winnipeg, Canada
5Carleton University, Ottawa, Canada

Tài liệu tham khảo

Thông tin
Thông tin xuất bản

Multiple Sclerosis and Related Disorders

Tập 61

103779

Thông tin tác giả